P
CHE icon

&Partners’s Chemed CHE Stock Holding History

&Partners’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
583
-779
-57% -$328K ﹤0.01% 2198
2026
Q1 		$516K Sell
1,362
-875
-39% -$375K ﹤0.01% 1678
2025
Q4 		$957K Sell
2,237
-372
-14% -$162K 0.01% 1241
2025
Q3 		$1.17M Buy
2,609
+203
+8% +$91.9K 0.01% 1012
2025
Q2 		$1.17M Buy
2,406
+336
+16% +$191K 0.01% 906
2025
Q1 		$1.25M Buy
2,070
+43
+2% +$24.4K 0.01% 733
2024
Q4 		$1.09M Buy
2,027
+131
+7% +$73.8K 0.01% 733
2024
Q3 		$1.14M Buy
1,896
+35
+2% +$19.8K 0.02% 530
2024
Q2 		$1.01M Buy
+1,861
New +$1.07M 0.04% 350

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

&Partners's CHE Position: Q2 2026 in Review

&Partners reduced its Chemed (CHE) stake by 57% in Q2 2026, selling an estimated $328K and leaving 583 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

&Partners first reported a position in CHE in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.25M in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • &Partners held 583 shares of Chemed worth $272K as of Q2 2026.
  • &Partners sold 779 Chemed shares in Q2 2026, an estimated $328K.
  • Chemed made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2198 holding.
  • &Partners first reported a position in Chemed in Q2 2024 and has held it in 9 quarters since.
  • &Partners's Chemed position peaked at $1.25M in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.